Examination of hemostatic parameters to detect hypercoagulability in dogs with severe protein-losing nephropathy

Journal of Veterinary Emergency and Critical Care

Volumn 21, Issue 4, 2011, Pages 346-355

  Donahue, Suzanne M ^a,c   Brooks, Marjory ^b   Otto, Cynthia M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Department of Molecular Biology and Genetics   (United States)

^c Veterinary Referral Center   (United States)

Author keywords

Canine; Glomerular disease; Thromboelastography; Thrombosis

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING TEST; CROSS-SECTIONAL STUDY; DOG; DOG DISEASE; KIDNEY DISEASE; PROTEINURIA; THROMBOPHILIA;

ANIMALS; BLOOD COAGULATION TESTS; CROSS-SECTIONAL STUDIES; DOG DISEASES; DOGS; KIDNEY DISEASES; PROTEINURIA; THROMBOPHILIA;

ANIMALIA; CANIS FAMILIARIS;

EID: 80051472239     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2011.00656.x     Document Type: Article

References (65)

1. Green RA, Kabel AL. Hypercoagulable state in three dogs with nephrotic syndrome: role of acquired antithrombin III deficiency. J Am Vet Med Assoc 1982; 181 (9):914-917.
2. Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992). J Am Anim Hosp Assoc 1996; 32 (4):313-322.
3. Virchow R. Ein vortrag uber die thrombose vom jahre 1845, In: Virchow R. ed. Gesammelte abhandlungen zur wissenshaftlichen medizin. Frankfurt: Meidinger Sohn u. Co; 1856, pp. 478-481.
4. Rasedee A, Feldman BF, Washabau R. Naturally occurring canine nephrotic syndrome is a potentially hypercoagulable state. Acta Vet Scand 1986; 27 (3):369-377.
5. Ritt MG, Rogers KS, Thomas JS. Nephrotic syndrome resulting in thromboembolic disease and disseminated intravascular coagulation in a dog. J Am Anim Hosp Assoc 1997; 33 (5):385-391.
6. Green RA. Pathophysiology of antithrombin deficiency. Vet Clin North Am: Small An Pract 1988; 18 (1):95-104.
7. Citak A, Emre S, Sairin A, et al. Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol 2000; 14 (2):138-142.
8. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res 2006; 118 (3):397-407.
9. Jergens AE, Turrentine MA, Kraus KH, et al. Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von willebrand's disease. Am J Vet Res 1987; 48 (9):1337-1342.
10. Brassard JA, Meyers KM, Person M, et al. Experimentally induced renal failure in the dog as an animal model of uremic bleeding. J Lab Clin Med 1994; 124 (1):48-54.
11. Stein PD, Hull RD, Saltzman HA, et al. Strategy for diagnosis of patients with suspected acute pulmonary embolism. Chest 1993; 103 (5):1553-1559.
12. Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 1999; 13 (4):338-345.
13. Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998; 339 (2):93-104.
14. Mannucci PM, Giangrande PLF. Detection of the prethrombotic state due to procoagulant imbalance. Eur J Haematol 1992; 48:65-69.
15. Folsom AR, Cushman M, Heckbert SR, et al. Prospective study of fibrinolytic markers and venous thromboembolism. J Clin Epidemiol 2003; 56 (6):598-603.
16. Kruskal JB, Robson SC, Franks JJ, et al. Elevated fibrin-related and fibrinogen-related antigens in patients with liver disease. Hepatology 1992; 16 (4):920-923.
17. Sagripanti A, Cupisti A, Baicchi U, et al. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993; 63 (3):273-278.
18. Gordge MP, Faint RW, Rylance PB, et al. Plasma d dimer: a useful marker of fibrin breakdown in renal failure. Thromb Haemost 1989; 61 (3):522-525.
19. Pizzo SV, Pasqua JJ. The clearance of human fibrinogen fragments d1, d2, d3 and fibrin fragment d1 dimer in mice. Biochim Biophys Acta 1982; 718 (2):177-184.
20. Hartet H. Blutgerinnungsstudien mit der thrombelastographie einem neuen untersuchungsverfahren. Klin Wochenschr 1948; 26:577-583.
21. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106 (5):1366-1375.
22. Jessen LR, Wiinberg B, Jensen AL, et al. In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time. Vet Clin Pathol 2008; 37 (4):363-372.
23. Kristensen AT, Wiinberg B, Jessen LR, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008; 22 (1):140-147.
24. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008; 22 (2):357-365.
25. Wiinberg B, Jensen AL, Kjelgaard-Hansen M, et al. Study on biological variation of haemostatic parameters in clinically healthy dogs. Vet J 2007; 174 (1):62-68.
26. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005; 34 (4):389-393.
27. Wiinberg B, Jensen AL, Rozanski E, et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 2009; 179 (1):121-129.
28. Kraft W. Thrombelastogram in healthy domestic cats and therapy of disseminated intravascular coagulation (dic) in panleukopenia. Berl Munch Tierarztl Wochenschr 1973; 86 (20):394-396.
29. von Schaewen H. Thrombelastographic studies and thrombocyte counts in dogs. Berl Munch Tierarztl Wochenschr 1971; 84 (17):324-328.
30. Kaspareit J, Messow C, Edel J. Blood coagulation studies in guineapigs (cavia porcellus). Lab Anim 1988; 22 (3):206-211.
31. Otto C, Rieser T, Brooks M, Russell M. Evidence of hypercoagulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000; 217 (10):1500-1504.
32. Brainard BM, Meredith CP, Callan MB, et al. Changes in platelet function, hemostasis, and prostaglandin expression after treatment with nonsteroidal anti-inflammatory drugs with various cyclooxygenase selectivities in dogs. Am J Vet Res 2007; 68 (3):251-257.
33. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care 2009; 19 (5):484-488.
34. Stokol T, Brooks MB, Erb HN. Effect of citrate concentration on coagulation test results in dogs. J Am Vet Med Assoc 2000; 217 (11):1672-1677.
35. Lanevschi A, Kramer JW, Greene SA, et al. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs. Am J Vet Res 1996; 57 (8):1124-1130.
36. Benson RE, Catalfamo JL, Brooks M, et al. A sensitive immunoassay for von Willebrand factor. J Immunoassay 1991; 12 (3):371-390.
37. Gaffney PJ, Wong MY. Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thromb Haemost 1992; 68 (4):428-432.
38. Simmons JP, Wohl JS. Hypotension, In: Silverstein DC, Hopper K. eds. Small Animal Critical Medicine. Saunders: St Louis; 2009, pp. 27-30.
39. Mahla E, Lang T, Vicenzi MN, et al. Thromboelastography for monitoring prolonged hypercoagulability after major abdominal surgery [see comment]. Anesth Analg 2001; 92 (3):572-577.
40. Cook AK, Cowgill LD. Clinical and pathological features of protein-losing glomerular disease in the dog: a review of 137 cases (1985-1992). J Am Anim Hosp Assoc 1996; 32 (4):313-322.
41. Vilar P, Couto CG, Westendorf N, et al. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. J Vet Intern Med 2008; 22 (2):374-379.
42. Pivalizza EG, Abramson DC, Harvey A. Perioperative hypercoagulability in uremic patients: a viscoelastic study. J Clin Anesth 1997; 9 (6):442-445.
43. Holloway DS, Vagher JP, Caprini JA, et al. Thrombelastography of blood from subjects with chronic renal failure. Thromb Res 1987; 45 (6):817-825.
44. Adams MJ, Irish AB, Watts GF, et al. Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function. Thromb Res 2008; 123 (2):374-380.
45. Mischke R, Schulze U. Studies on platelet aggregation using the born method in normal and uraemic dogs. Vet J 2004; 168 (3):270-275.
46. Smith SA, McMichael M, Galligan A, et al. Clot formation in canine whole blood as measured by rotational thromboelastometry is influenced by sample handling and coagulation activator. Blood Coagul Fibrinolysis 2010; 21 (7):692-702.
47. Johansson PI, Bochsen L, Andersen S, et al. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion (Paris) 2008; 48 (11):2377-2383.
48. Dai Y, Lee A, Critchley LA, et al. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009; 108 (3):734-742.
49. Littman MP, Goldstein RE, Labato MA, et al. ACVIM small animal consensus statement on lyme disease in dogs: diagnosis, treatment, and prevention. J Vet Intern Med 2006; 20 (2):422-434.
50. Dambach DM, Smith CA, Lewis RM, et al. Morphologic, immunohistochemical, and ultrastructural characterization of a distinctive renal lesion in dogs putatively associated with borrelia burgdorferi infection: 49 cases (1987-1992). Vet Pathol 1997; 34 (2):85-96.
51. Grauer GF, Burgess EC, Cooley AJ, et al. Renal lesions associated with borrelia burgdorferi infection in a dog. J Am Vet Med Assoc 1988; 193 (2):237-239.
52. Hutton TA, Goldstein RE, Njaa BL, et al. Search for borrelia burgdorferi in kidneys of dogs with suspected "Lyme nephritis." J Vet Intern Med 2008; 22 (4):860-865.
53. Chou J, Wunschmann A, Hodzic E, et al. Detection of borrelia burgdorferi DNA in tissues from dogs with presumptive lyme borreliosis. J Am Vet Med Assoc 2006; 229 (8):1260-1265.
54. Bowman D, Little SE, Lorentzen L, et al. Prevalence and geographic distribution of dirofilaria immitis, borrelia burgdorferi, ehrlichia canis, and anaplasma phagocytophilum in dogs in the united states: results of a national clinic-based serologic survey. Vet Parasitol 2009; 160 (1-2):138-148.
55. Nelson OL, Andreasen C, Nelson OL, et al. The utility of plasma D-dimer to identify thromboembolic disease in dogs. J Vet Intern Med 2003; 17 (6):830-834.
56. Rivera Ramirez PA, Deniz A, Wirth W, et al. Antithrombin III activity in healthy cats and its changes in selected disease. Berl Munch Tierarztl Wochenschr 1997; 110 (11-12):440-444.
57. Pabinger-Fasching I, Lechner K, Niessner H, et al. High levels of plasma protein c in nephrotic syndrome. Thromb Haemost 1985; 53 (1):5-7.
58. Sorensen PJ, Knudsen F, Nielsen AH, et al. Protein c activity in renal disease. Thromb Res 1985; 38 (3):243-249.
59. Ariens RA, Moia M, Rivolta E, et al. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria. Thromb Haemost 1999; 82 (3):1020-1023.
60. Malyszko J, Malyszko JS, Mysliwiec M. Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome. Blood Coagul Fibrinolysis 2002; 13 (7):615-621.
61. Mannucci PM, Valsecchi C, Bottasso B, et al. High plasma levels of protein c activity and antigen in the nephrotic syndrome. Thromb Haemost 1986; 55 (1):31-33.
62. Ozkayin N, Mir S, Kavakli K, et al. Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-c activity. Int Urol Nephrol 2004; 36 (4):599-603.
63. Ibarra-Rubio ME, Pedraza-Chaverri J, Panduro A. Differential regulation in the expression of hepatic genes in nephrotic and pair-fed rats. Nephron 1993; 65 (1):119-124.
64. Miao CH, Ho WT, Greenberg DL, et al. Transcriptional regulation of the gene coding for human protein c. J Biol Chem 1996; 271 (16):9587-9594.
65. Kottke-Marchant K, Comp P, Kottke-Marchant K, et al. Laboratory issues in diagnosing abnormalities of protein c, thrombomodulin, and endothelial cell protein c receptor. Arch Pathol Lab Med 2002; 126 (11):1337-1348.